Want to see NVS full AI Analyst Report?
Novartis (NVS) Stock Forecast & Price Target
NVS Analyst Ratings
NVS Stock 12 Month Forecast
Average Price Target
$159.67▼(-1.40% Downside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Thibault Boutherin | Morgan Stanley | $156→$163 | buy | 0.66%Upside | Reiterated | 10/28/26 | ||
| Sachin Jain | Bank of America Securities | ― | buy | ― | Reiterated | 10/27/26 | ||
| Rajesh Kumar | HSBC | $123→$136 | hold | -16.01%Downside | Upgraded | 09/10/26 | ||
| Steve Scala | TD Cowen | $180 | hold | 11.16%Upside | Reiterated | 09/08/26 | ||
| Kerry Holford | Berenberg Bank | $141→$147 | hold | -9.22%Downside | Reiterated | 07/27/26 | ||
| Jasper Hellweg | Argus Research | $170 | buy | 4.98%Upside | Reiterated | 07/24/26 | ||
 Unknown AnalystNot Ranked | Goldman Sachs | $140→$139 | sell | -14.16%Downside | Reiterated | 07/22/26 | ||
| Justin Smith | Bernstein | ― | hold | ― | Initiated | 03/19/26 | ||
| Emily Field | Barclays | ― | hold | ― | Upgraded | 01/06/26 | ||
| Richard Vosser | J.P. Morgan | ― | hold | ― | Reiterated | 11/20/25 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Thibault BoutherinMorgan Stanley | BuyReiterated$156→$163 | 10/28/26 | 0.66%Upside | ||
| Sachin JainBank of America Securities | BuyReiterated | 10/27/26 | ― | ||
| Rajesh KumarHSBC | HoldUpgraded$123→$136 | 09/10/26 | -16.01%Downside | ||
| Steve ScalaTD Cowen | HoldReiterated$180 | 09/08/26 | 11.16%Upside | ||
| Kerry HolfordBerenberg Bank | HoldReiterated$141→$147 | 07/27/26 | -9.22%Downside | ||
| Jasper HellwegArgus Research | BuyReiterated$170 | 07/24/26 | 4.98%Upside | ||
| Unknown AnalystGoldman SachsNot Ranked | SellReiterated$140→$139 | 07/22/26 | -14.16%Downside | ||
| Justin SmithBernstein | HoldInitiated | 03/19/26 | ― | ||
| Emily FieldBarclays | HoldUpgraded | 01/06/26 | ― | ||
| Richard VosserJ.P. Morgan | HoldReiterated | 11/20/25 | ― |
Best Analysts Covering Novartis
Copying Thibault Boutherin's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +13.20% per trade.
Copying Thibault Boutherin's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +13.60% per trade.
Copying OpenAI Drug Manufacturers - General's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +17.03% per trade.
NVS Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 7 | 7 |
| Hold | 4 | 3 | 4 | 2 | 2 |
| Sell | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 9 | 8 | 9 | 9 | 9 |
In the current month, NVS has received 7 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. NVS average Analyst price target in the past 3 months is 159.67.
NVS Financial Forecast
NVS Earnings Forecast
Next quarter’s earnings estimate for NVS is $2.25 with a range of $2.12 to $2.35. The previous quarter’s EPS was $2.46. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NVS Sales Forecast
Next quarter’s sales forecast for NVS is $14.65B with a range of $14.01B to $15.24B. The previous quarter’s sales results were $14.44B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
